CardioGenics

About:

CardioGenics develops sensitive diagnostic test products to the IVD market.

Description:

CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective “to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies”.

Total Funding Amount:

$4.63M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Çan, Canakkale, Turkey

Founded Date:

1997-01-01

Contact Email:

info(AT)cardiogenics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2011-02-09

IPO Status:

Public

Industries: